Merck Animal Health Receives FDA Approval of BRAVECTO ® (fluralaner topical solution) for Cats and Dogs
< div class= " field field-type-text field-field-press-release-city field-fieldpressreleasecity " > < div class= " field-label " > Dateline City: < /div > < div class= " field-items " > < div class= " field-item odd " >
MADISON, N.J. < /div > < /div > < /div > < div class= " field field-type-text field-field-press-release-subheadline field-fieldpressreleasesubheadline " > < div class= " field-items " > < div class= " field-item odd " > < p > Topical Treatment for Fleas and Ticks Effective for up to 12 Weeks < /p > < /div > < /div > < /div > < p > MADISON, N.J.--( < a target= " _blank " href= " http://www.businesswire.com " > BUSINESS WIRE < /a > )--Merck Animal Health, known as MSD Animal Health outside of the United
States and Canada, today announced the U.S. Food and Drug
Administration ’s approval of BRAVECTO < sup > ® < /sup > (fluralaner topical
solution) for both cats and dogs, a topical treatment for fleas and
ticks effective for up to 12 weeks < sup > 1,2 < /sup > following a single dose. < /p > < div class= " field field-type-text field-field-press-release-language field-fieldpressreleaselanguage " > < div class= " field-label " > Language: < /div > < div class= " field-items " > < div class= " field-item odd " >
English < /div > < /div > < /div > < div class= " field field-type-text field-field-press-release-contact-html field-fieldpressreleasecontacthtml " > < div class= " field-l...